CytoDyn Inc.·4

Feb 25, 5:07 PM ET

Eastwood Craig S. 4

4 · CytoDyn Inc. · Filed Feb 25, 2020

Insider Transaction Report

Form 4
Period: 2020-02-21
Eastwood Craig S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-02-21+150,000150,000 total
    Exercise: $1.10Exp: 2030-02-21Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The options will fully vest on February 21, 2021.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION